Abstract
Introduction Guideline developers have increasingly engaged various groups of interest-holders in different stages of guideline development. However, reporting on interest-holder engagement in practice guidelines often lacks transparency. Therefore, the RIGHT (Reporting Items of Practice Guidelines in Healthcare) working group, in collaboration with the MuSE Consortium, plans to develop the RIGHT-MuSE extension.
Objectives This protocol aims to outline the steps for the detailed development of the RIGHT-MuSE checklist, as well as strategies for its effective development, dissemination, and application.
Methods We will follow the methods recommended by the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network, and build on the experience from the development of the original RIGHT statement and its extensions. The development process of RIGHT-MuSE will consist of twelve specific steps: 1. Identifying the need for the checklist; 2. Obtaining funding; 3. Drafting a protocol and registering the project; 4. Establishing the working groups; 5. Reviewing background work; 6. Generating an initial list of items; 7. Conducting consensus surveys; 8. Holding consensus meetings; 9. Drafting the final RIGHT-MuSE checklist; 10. Conducting a pilot test of the checklist; 11. Developing an explanatory document; and 12. Disseminating the checklist.
Discussion The RIGHT-MuSE checklist will provide guideline developers with guidance for the systematic, scientific and transparent reporting of interest-holder engagement in practice guidelines. Additionally, developers and implementers of the RIGHT-MuSE checklist will use this protocol as a reference to ensure that the checklist they develop and implement adheres to the highest standards of transparency and quality. By promoting active and meaningful engagement of interest-holders, the RIGHT-MuSE checklist aims to foster inclusive and people centered processes in healthcare.
Competing Interest Statement
Dr. Xuan Yu's salary is funded by the Vincent and Lily Woo Foundation. Dr. Zhaoxiang Bian is the co-director of the Vincent V.C. Woo Chinese Medicine Clinical Research Institute, which is funded by the Vincent and Lily Woo Foundation. Dr. Yaolong Chen is the director of the Research Unit of Evidence-based Evaluation and Guidelines (2021RU017), funded by the CAMS Innovation Fund.
Funding Statement
This project was funded by the Vincent and Lily Woo Foundation and CAMS Innovation Fund for Medical Sciences - Research Unit of Evidence-based Evaluation and Guidelines (2021RU017). The funders have no role in the study design, data collection and analysis, manuscript writing, or publication process.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
All data from this protocol are available upon reasonable request. Please contact the corresponding authors for details.
